Please select a Capability in order to start your service request.
2014 Sustainability Report outlines new integrated strategy and goals to create more sustainable healthcare solutionsJul 13, 2015
FRANKLIN LAKES, N.J., July 13, 2015 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today an updated sustainability strategy and goals for 2020 as part of the release of its 2014 Sustainability Report.
The company’s new goals reflect a broader and more integrated agenda than in past years, recognizing four strategic areas where BDwill focus its efforts and reporting going forward:
“BD sees the social and environmental challenges our world faces today as an opportunity to make a difference while strengthening our company,” said Vincent A. Forlenza, BDchairman, chief executive officer and president. “Our sustainability strategy has evolved to address the wide range of challenges in our industry, while helping to make a difference on relevant issues that affect society and the planet. In addition to our ongoing focus to improve environmental performance, our sustainability strategy now takes a broader view of BD’s role in addressing global societal issues.”
This is BD’s seventh annual Sustainability Report, highlighting progress achieved within the company’s past fiscal year between Oct. 1, 2013 and Sept. 30, 2014. The company plans to continue its long history of shared value creation, which addresses unmet societal needs through business models and initiatives that also contribute to commercial success.
Achievement of 2015 Targets
The report also presents the results of BD’s 2015 sustainability goals – the company’s first set of strategic sustainability priorities and performance targets set in 2009 that related to environmental footprint reduction.
BDexceeded four of its five targets for 2015 and is making significant progress toward achieving its energy reduction goals. As a result, the company has delivered more than $25 million in cost savings through the significant improvement of its environmental performance over the last five years.
To view the full BD2014 Sustainability Report, visit www.bd.com/sustainability2014.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.